Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Trials
Collaboration
Funding
Validation
Study findings presented on early stroke-type detection test
By
LabPulse.com staff writers
A new blood test may rapidly distinguish stroke type before people with stroke symptoms reach the emergency department, according to a preliminary study being presented at the American Stroke Association's International Stroke Conference 2025.
February 5, 2025
Oncocyte releases data on transplant rejection assay
By
LabPulse.com staff writers
Diagnostics developer Oncocyte has announced study data showing that its monitoring assay for kidney transplant rejection significantly reduces the time to diagnosis.
December 4, 2024
BioAffinity secures $2.7M to advance novel lung cancer diagnostic test
By
LabPulse.com staff writers
Texas-based bioAffinity Technologies has secured nearly $2.7 million at the close of a registered direct stock offering that it will use for general corporate purposes, including working capital, to advance its novel CyPath Lung test.
October 24, 2024
Immunovia announces positive results for next-gen pancreatic cancer test
By
LabPulse.com staff writers
Diagnostics company Immunovia announced positive results for the newest generation of its pancreatic cancer test from a model-development study, announcing that the test achieved both its primary and secondary endpoints.
April 25, 2024
Castle Biosciences shares melanoma test study data at SSO 2024
By
LabPulse.com staff writers
Castle Biosciences shared data from two studies on the performance of its DecisionDx-Melanoma test in patients with cutaneous melanoma at the Society of Surgical Oncology 2024 (SSO 2024) annual meeting, held March 20-23 in Atlanta.
March 26, 2024
ChromaCode partners with the Medical College of Georgia on NSCLC assay validation
By
LabPulse.com staff writers
ChromaCode announced a partnership with the Medical College of Georgia to test the analytical and clinical performance of ChromaCode's HDPCR non-small cell lung cancer (NSCLC) biomarker assay.
March 21, 2024
Novartis presents first results of SMART spinal muscular atrophy study
By
LabPulse.com staff writers
Company presents new data from a clinical study, called the SMART study, of its gene therapy in previously treated patients and a broader patient population.
March 5, 2024
‘Remarkable’ results in lupus patients spark speculation CAR-T may cure autoimmunity
By
Nick Paul Taylor
The generation of “remarkable” results in lupus patients has sparked speculation about the potential for chimeric antigen receptor T-cell (CAR-T cell) therapy to cure autoimmune diseases.
February 23, 2024
U.K. trial for mRNA-based cancer therapy begins
By
Matt Limb
Cancer patients in the U.K. are receiving an experimental mRNA therapy designed to help their bodies recognize and fight cancer cells.
February 7, 2024
AI-powered blood test supports risk stratification of heart disease patients
By
Nick Paul Taylor
A blood test powered by artificial intelligence (AI) has shown promise in the assessment of patients with total blockage of a heart artery.
November 27, 2023
HIV vaccine trial begins enrollment in U.S., South Africa
By
LabPulse.com staff writers
A clinical trial for a preventive HIV vaccine has begun enrollment in both the U.S. and South Africa.
September 25, 2023
Moderna’s mRNA flu shot yields promising results in phase III trial
By
LabPulse.com staff writers
Moderna announced that its mRNA flu shot that is in development has met its primary endpoints in a phase III trial, generating a stronger immune response than a commercially available flu vaccine.
September 15, 2023
Page 1 of 9
Next Page